MIRA INFORM REPORT
|
Report Date : |
27.01.2014 |
IDENTIFICATION DETAILS
|
Name : |
HENRY’S PHARMACEUTICALS (PVT) LIMITED |
|
|
|
|
Registered Office : |
# 201,Sri Sangaraja Mawatha, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
30.09.1998 |
|
|
|
|
Com. Reg. No.: |
N(PVS) 22168 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Import and Distributors of Pharmaceutical Products. |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2013
|
Country Name |
Previous Rating (30.06.2013) |
Current Rating (30.09.2013) |
|
Sri Lanka |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SRI LANKA - ECONOMIC OVERVIEW
Sri Lanka continues to experience strong economic growth following the end of the 26-year conflict with the Liberation Tigers of Tamil Eelam (LTTE). The government has been pursuing large-scale reconstruction and development projects in its efforts to spur growth in war-torn and disadvantaged areas, develop small and medium enterprises and increase agricultural productivity. The government's high debt payments and bloated civil service have contributed to historically high budget deficits, but fiscal consolidation efforts and strong GDP growth in recent years have helped bring down the government's fiscal deficit. However, low tax revenues are a major concern. The 2008-09 global financial crisis and recession exposed Sri Lanka''s economic vulnerabilities and nearly caused a balance of payments crisis. Growth slowed to 3.5% in 2009. Economic activity rebounded with the end of the war and an IMF agreement, resulting in two straight years of 8% growth in 2010-11. Growth moderated to about 6% in 2012. Agriculture slowed due to a drought and weak global demand affected exports and trade. In early 2012, Sri Lanka floated the rupee, resulting in a sharp depreciation, and took steps to curb imports. A large trade deficit remains a concern. Strong remittances from Sri Lankan workers abroad have helped to offset the trade deficit
|
Source
: CIA |
Basic information at a glance
|
a. |
Name of Subject of Inquiry |
: |
HENRY’S PHARMACEUTICALS (PVT) LIMITED |
|
b. |
Legal Form & Status |
: |
Private Limited Liability Company (In Operation) |
|
c. |
Chairman |
: |
Kumar Anton Rohita Bulathwela |
|
d. |
Primary Line of Business |
: |
Import And Distributors of Pharmaceutical Products. |
|
e. |
Place of Business |
: |
# 201,Sri Sangaraja Mawatha, Colombo 10, Sri Lanka Tel. No: (00 94 11) 233 7471 Fax No: (00 94 11)
E Mail: info@henryspharama.net |
Registration and Shareholder Details
|
a. |
Registration No |
: |
N(PVS) 22168 |
|
|
Date of Registration |
: |
30th September 1998 |
||
|
b. |
Re-registration No |
|
PV 16751 |
|
|
Date of Re-registration |
|
09th November 2009 |
||
|
c. |
Registered Office |
: |
# 201, Sri Sangaraja Mawatha, Colombo-10. |
|
|
d. |
Board of Directors As at 31th December 2012 |
|
K.A.Rohita Bulathwela |
Managing Director |
|
H.S.Priyantha Bulathwela |
Director |
|||
|
A.C.Janaka Gunawardena |
Director |
|||
|
A.M.Swarna Peris ( Alternate to K.A.Rohita Bulathwela) |
Director |
|||
|
e. |
Issued Share Capital |
: |
Rs. 10,510,050.00 |
|
|
f. |
Nominal Value of Share |
: |
Rs. 10.00 |
|
Registration and Shareholder Details
|
g. |
Share Holders As at 31th December 2012 |
: |
Share Holders |
No. of
Shares |
|
|
C.A.Wijeyeweere |
1,000,000 |
||||
|
S.K.Bridget Mary Fernando |
50,661 |
||||
|
H.S.Priyantha Bulawela |
201 |
||||
|
A.C.Janaka Gunawardena |
11 |
||||
|
S. Danesh Ranjith |
11 |
||||
|
S.J. Nihal Rienzie Fernando |
21 |
||||
|
C. Gunasekara |
100 |
||||
|
h. |
Secretaries |
: |
H.P.N.Secretarial Services (PVT) LTD |
||
|
i. |
Auditors |
: |
P.Wijayawardana and Company |
||
|
j. |
Bankers |
: |
Not Disclosed |
||
Most recent available Financial Information
Based on the corporate laws of Sri Lanka, legal entities which are Private Company with Limited Liability is not required to make public disclosure of their annual financials. Therefore no financials are available for this entity
History.
The Subject Company HENRY`S PHARMACEUTICALS (PVT) LTD is a Private Limited liability Company incorporated in 30th August 1998 under registration number N(PVS) 22168 and the company was re-registered on 09th Octomber 2009sunder registration number PV 16751 in terms of Companies Act #7 of 2007.
The subject company initially known as a “GAULA INTERNATIONAL(PVT) LTD” and the name has been changed on 12st
January 2010 to the present new name “HENRY`S
PHARMACEUTICALS (PVT) LTD.”
Location.
The subject company is located at client # 201, Sri Sangaraja Mawatha, Colombo-10,
Operational Details.
General
The subject company’s primary line of business is Import and Distributors of Pharmaceutical Products.
Products
Drugs and Pharmaceutical Products
Import Country
Pakistan, India, Thailand
01)
|
Name |
K.A. Rohita
Bulathwela |
|
ID Number |
591053515V |
|
Nationality |
Sri Lankan |
|
Gender |
Male |
|
Date Of Birth |
14th March 1959 |
|
Age |
54 Years |
02)
|
Name |
H.S.Priyantha
Bulathwela |
|
ID Number |
572721078V |
|
Nationality |
Sri Lankan |
|
Gender |
Male |
|
Date Of Birth |
28th September 1957 |
|
Age |
56 Years |
03)
|
Name |
A.C. Janaka
Gunawardena |
|
ID Number |
61033231V |
|
Nationality |
Sri Lankan |
|
Gender |
Male |
|
Date Of Birth |
02th February 1961 |
|
Age |
52 Years |
04)
|
Name |
A.M.Swarna Peirs |
|
ID Number |
515572759V |
|
Nationality |
Sri Lankan |
|
Gender |
Female |
|
Date Of Birth |
26th February 1951 |
|
Age |
62 Years |
Financial Data
Based on the corporate laws of Sri Lanka, legal entities which are Private Company with
Limited Liability is not required to make public disclosure of their annual financials.
Therefore no financials are available for this entity
Trade references
Cosmetic Devices
& Drugs Regulatory Authority
Credit Recommendations
Since no financial information has been forthcoming from the company, it is not possible to comment on the merits or otherwise of the company.
No computerised data
bases exist to make checks whether the partners or the company has any legal
action or lawsuit initiated against any of them but informal (but not in-depth)
checks do not indicate any such cases in the public knowledge.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.18 |
|
|
1 |
Rs.103.38 |
|
Euro |
1 |
Rs.85.09 |
INFORMATION DETAILS
|
Report Prepared
by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to
overcome financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.